Considering the role of megalin in regulating the availability of fibrotic molecules, the decrease of megalin expression induced by its own ligands (and by TGF-ß) could be associated with the evolution and/or the severity of some pathological conditions, such as fibrosis and cancer, in different megalin-expressing epithelial tissues. This evidence concerns the gene LRP2 and cancer.